Hypothesis: Human serum-borne albumin bound lipids promote cellular survival after apoptosis induction by a variety of stimuli

Apoptosis

Volumn 13, Issue 2, 2008, Pages 319-328

  Schiller, Martin ^a   Franz, Sandra ^b   Heyder, Petra ^a   Voll, Reinhard E ^c   Gaipl, Udo S ^b   Lorenz, Hanns Martin ^a   Kalden, Joachim R ^b   Herrmann, Martin ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Apoptosis; Lipids; Serum

Indexed keywords

ALBUMIN; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STAUROSPORINE;

APOPTOSIS; ARTICLE; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; GEL FILTRATION; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; ULTRAVIOLET IRRADIATION;

APOPTOSIS; CELL SURVIVAL; ENZYME INHIBITORS; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPIDS; ONCOGENE PROTEIN V-AKT; OXIDATIVE STRESS; SERUM; SERUM ALBUMIN; STAUROSPORINE;

EID: 38649083130     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-007-0168-3     Document Type: Article

References (26)

1. Bohana-Kashtan O, Ziporen L, Donin N, Kraus S, Fishelson Z (2004) Cell signals transduced by complement. Mol Immunol 41:583-597
2. Dashiell SM, Rus H, Koski CL (2000) Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosis. Glia 30:187-198
3. Soane L, Cho HJ, Niculescu F, Rus H, Shin ML (2001) C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway. J Immunol 167:2305-2311
4. Rus HG, Niculescu F, Shin ML (1996) Sublytic complement attack induces cell cycle in oligodendrocytes. J Immunol 156:4892-4900
5. Rus HG, Niculescu FI, Shin ML (2001) Role of the C5b-9 complement complex in cell cycle and apoptosis. Immunol Rev 180:49-55
6. Halperin JA, Taratuska A, Nicholson-Weller A (1993) Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells. J Clin Invest 91:1974-1978
7. Guo RF, Huber-Lang M, Wang X et al (2000) Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J Clin Invest 106:1271-1280
8. Del Castillo G, Murillo MM, Alvarez-Barrientos A et al (2006) Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: role of EGF receptor ligands. Exp Cell Res 312:2860-2871
9. Varela-Nieto I, Hartl M, Gorospe I, Leon Y (2007) Anti-apoptotic actions of insulin-like growth factors: lessons from development and implications in neoplastic cell transformation. Curr Pharm Des 13:687-703
10. Van Golen CM, Feldman EL (2000) Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis. J Cell Physiol 182:24-32
11. Staiger H, Loffler G (1998) The role of PDGF-dependent suppression of apoptosis in differentiating 3T3-L1 preadipocytes. Eur J Cell Biol 77:220-227
12. Kang YC, Kim KM, Lee KS et al (2004) Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation. Cell Death Differ 11:1287-1298
13. Zheng ZQ, Fang XJ, Qiao JT (2004) Dual action of lysophosphatidic acid in cultured cortical neurons: survival and apoptogenic. Sheng Li Xue Bao 56:163-171
14. Raj GV, Sekula JA, Guo R, Madden JF, Daaka Y (2004) Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-kappaB. Prostate 61:105-113
15. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279
16. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B (2007) Mitochondria, oxidative stress and cell death. Apoptosis 12:913-922
17. Gogvadze V, Orrenius S (2006) Mitochondrial regulation of apoptotic cell death. Chem Biol Interact 163:4-14
18. Carmody RJ, Cotter TG (2001) Signalling apoptosis: a radical approach. Redox Rep 6:77-90
19. Schiller M, Blank N, Heyder P et al (2005) Induction of apoptosis by spermine-metabolites in primary human blood cells and various tumor cell lines. Apoptosis 10:1151-1162
20. Dzagnidze A, Katsarava Z, Makhalova J et al (2007) Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy. J Neurosci 27:9451-9457
21. Ober M, Lippard SJ (2007) Cisplatin damage overrides the predefined rotational setting of positioned nucleosomes. J Am Chem Soc 129:6278-6286
22. Jung Y, Lippard SJ (2006) RNA polymerase II blockage by cisplatin-damaged DNA. Stability and polyubiquitylation of stalled polymerase. J Biol Chem 281:1361-1370
23. Mastrandrea LD, Sessanna SM, Laychock SG (2005) Sphingosine kinase activity and sphingosine-1 phosphate production in rat pancreatic islets and INS-1 cells: response to cytokines. Diabetes 54:1429-1436
24. Meng Y, Kang S, Fishman DA (2005) Lysophosphatidic acid inhibits anti-Fas-mediated apoptosis enhanced by actin depolymerization in epithelial ovarian cancer. FEBS Lett 579:1311-1319
25. Meng Y, Kang S, So J, Reierstad S, Fishman DA (2005) Translocation of Fas by LPA prevents ovarian cancer cells from anti-Fas-induced apoptosis. Gynecol Oncol 96:462-469
26. Lystad E, Hostmark AT, Kiserud C, Haugen A (1994) Influence of fatty acids and bovine serum albumin on the growth of human hepatoma and immortalized human kidney epithelial cells. In Vitro Cell Dev Biol Anim 30A:568-573